HELP     Sign In

2q23.3-q24.1CNV Type: Deletion


Largest CNV size: 3600000 bp

Statistics Box:
Number of Reports: 5



Summary Information

Summary statement in development

Additional Locus Information

Genome browsers

USCS Symbol             NCBI Symbol

Decipher

            Decipher Symbol

References

Major Reports

Title
Author, Year
Report Class
CNV Type
Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder
Deletion-Duplication
NA
Duplication
De novo variants of NR4A2 are associated with neurodevelopmental disorder and epilepsy
Deletion

Minor Reports

Title
Author, Year
Report Class
CNV Type
Mapping of partially overlapping de novo deletions across an autism susceptibility region (AUTS5) in two unrelated individuals affected by developm...
Deletion
Genetic Testing in Patients with Neurodevelopmental Disorders: Experience of 511 Patients at Cincinnati Children's Hospital Medical Center
Deletion

Cases

Cohort ID
Author, Year
Descripton
Cohort Size
Diagnosis
Age
Gender
CNV Size
Deletion
Duplication
Total CNV's
 du_21_ASD/DD/ID/EP_discovery_cases
 Individuals who had a Neurodevelopmental Reflex (NDR) panel ordered through Cincinnati Children's Hospital Medical Center (CCHMC) from January 2018 to April 2019.
 511
 Common clinical indications for patients in this cohort included autism spectrum disorder (ASD), developmental delay(DD), speech delay, intellectual disability (ID), gross motor delay, mixed receptive-expressive language disorder, epilepsy (EP), and/or dysmorphic features.
 Range, 3 mos.-35 yrs. (median age, 3 yrs.)
 73.6% Male
 4353584
 1
 0
 1
 newbury_08_ASD/DD_discovery_cases
 Two patients assessed by a single clinician to have shared developmental delays & severe expressive communication deficits between individuals
 2
 1 diagnosed with mild developmental delay, 1 diagnosed with PDD-NOS
 ~12 yrs for both
 Female
 3600000
 1
 0
 1
 singh_20_DD/ID/EP_discovery_cases
 Unrelated indivduals with variants affecting the NR4A2 gene
 9
 All 9 cases presented with developmental delay; 8 cases presented with intellectual disability, 6 cases presented with seizures, and 1 case presented with autism
 Mean age 12.4 years (range 243 years)
 44.44% Male
 3698031
 1
 0
 1
 yuen_17_ASD_discovery_cases
 ASD genomes (1745 ASD probands, 879 ASD-affected siblings, 1 ASD-affected father, and 1 ASD-affected grandfather) from AGRE (n=730), the AGRE; Autism Treatment Network cohort (n=192) ,the ASD: Genomes to Outcomes Study cohort (n=1421), the Baby Siblings Research Consortium (n=43), the Baby Siblings Research Consortium; The Autism Simplex Collection cohort (n=6), the Infant Sibling Study (n=62), th
 2626
 ASD diagnosis of research quality when meeting criteria on one (n=437) or both (n=1361) of the diagnostic measures ADI-R and ADOS; clinical diagnosis of ASD (n=819) when given by expert clinician according to DSM-IV or DSM-5
 N/A
 78.71% Male
 6912000
 1
 1
 2
 zarrei_19_ASD/ADHD/OCD/SCZ_discovery_cases
  NA NA
 Samples with neurodevelopmental disorders (NDDs) mostly from the province of Ontario, Canada
 2691
 1,838 cases diagnosed with ASD, 427 with ADHD, 204 with schizophrenia, and 222 with OCD
 
 76.37% Male
 3070875
 0
 1
 1

Controls

Cohort ID
Author, Year
Descripton
Cohort Size
Diagnosis
Age
Gender
CNV Size
Deletion
Duplication
Total CNV's
 girirajan_13a_ASD_discovery_controls2
 Controls characterized through the Wellcome Trust Case-Control Consortium (WTCCC) for smaller hotspot regions and candidate-gene events
 2090
 Control
 NA
 NA
 N/A
 1
 0
 1

Cases

Cohort ID
Geographical Ancestry
Discovery Method
Platform
Algorithm
Software
Validation Method
 du_21_ASD/DD/ID/EP_discovery_cases
  United States
 Solid phase hybridization
  Illumina CytoSNP-850Kv1.2 BeadChip
 NA
 Illumina Genome Studio V2009.2
 None
 newbury_08_ASD/DD_discovery_cases
  British (1 Caucasian ancestry, 1 Chinese ancestry)
 FISH
 
 
 
 None
 singh_20_DD/ID/EP_discovery_cases
  NA
 aCGH
  Agilent 180K
 
 
 FISH
 yuen_17_ASD_discovery_cases
  N/A
 WGS
  Complete Genomics, Illumina HiSeq 2000, HiSeq X
 
 
 aCGH (Agilent 1M), array SNP (Affymetrix 6.0, Affymetrix CytoScan HD), solid phase hybridization (Illumina 1M, Illumina OMNI 2.5M)
 zarrei_19_ASD/ADHD/OCD/SCZ_discovery_cases
  74.1% European
 Array SNP
  Affymetrix CytoScan HD
 
 Affymetrix ChAS, iPattern, BioDiscovery Nexus, Partek Genomics Suite
 RT-qPCR or WGS

Controls

Cohort ID
Geographical Ancestry
Discovery Method
Platform
Algorithm
Software
Validation Method
  girirajan_13a_ASD_discovery_controls2
  NA
  Solid phase hybridization
  Illumina 1.2M SNP microarray
 
 
  None

Cases

Patient ID
Author, Year
Age
Gender
Primary Diagnosis
Clinical Profile
Cognitive Profile
CNV Start
CNV End
CNV Size
Genome Build
Type Method
Validation
  du_21_ASD/DD/ID_discovery_cases-case89
 2 yrs.
 M
 Developmental delay
 Global developmental delay, hypotonia
 
 151970381
 156323964
  4353584
 GRCh38
 Deletion
 No
  newbury_08_ASD/DD_discovery_cases-patient1
 12
 F
 Developmental delay
 Mild developmental delay, speech & language delay, social anxiety, sensory sensitivies, some rigidity of behaviors, normal motor milestones, recurrent infections, failure to thrive, short stature
 Age of 6 yrs: performance IQ 80, verbal IQ 73. Global learning difficulties at age 12.
 152282828
 155882830
  3600003
 GRCh38
 Deletion
 No
  singh_20_DD/ID/EP_discovery_cases-case9
 43 yrs.
 M
 DD, ID, epilepsy/seizures
 Developmental milestones: moderate developmental delay, developmental stagnation at 2.5 years. Motor and musculoskeletal evaluation: progressive ataxia in adulthood. Behavioral/psychiatric evaluation: hyperactivity, aggression, destructive behavior. Epilepsy/seizures: onset at 13 years; seizure types included absence sezures, tonic seizures, focal seizures with impaired awareness, and drop attacks. Brain imaging: enlarged cerebrospinal fluid spaces on MRI (patient 9 in this report).
 Moderate-to-severe intellectual disability
 153933699
 157631729
  3698031
 GRCh38
 Deletion
 Yes
  yuen_17_ASD_discovery_cases-case1-0484-003
 N/A
 N/A
 ASD
 Case cohort: ASD: Genomes to Outcome Study. Clinical description: Seizure disorder; asthma
 
 151609486
 158521488
  6912003
 GRCh38
 Deletion
 Yes
  yuen_17_ASD_discovery_cases-case1-0836-003
 N/A
 N/A
 ASD
 Case cohort: ASD: Genomes to Outcome Study. Clinical description: Intellectual Disability
 
 153826488
 156900488
  3074001
 GRCh38
 Duplication
 Yes
  zarrei_19_ASD/ADHD/OCD/SCZ_discovery_cases-case1-0836-003
  NA NA
 N/A
 F
 ASD
 Primary diagnosis: ASD. Additional phenotype(s): no additional phenotypes reported
 
 153826815
 156897690
  3070876
 GRCh38
 Duplication
 Yes

Controls

Patient ID
Author, Year
Age
Gender
Primary Diagnosis
Clinical Profile
Cognitive Profile
CNV Start
CNV End
CNV Size
Genome Build
Type Method
Validation
  girirajan_13a_ASD_discovery_controls2-control25
  N/A
  N/A
  Control
  N/A
  N/A
  N/A
  N/A
  N/A
  NCBI36
  Deletion
  No

Cases

Patient ID
Validation Description
Primary Disorder Inheritence
Inheritence
Family Profile
Disease Segregation
Gene Content
Altered Gene Expression
 du_21_ASD/DD/ID_discovery_cases-case89
 
 
 Unknown
 
 
 CACNB4,ATP5F1AP2,PRPF40A,RPRM,GALNT13,FMNL2,ARL6IP6,TUBAP13,CBX3P6,HEBP2P1,KCNJ3,DNAJA1P2,UBQLN4P2,RPL30P2,RPL23AP29,ATP5PBP4,RNA5SP107,MTND5P30,MTND2P20,MTND4P28,LINC01876,MTND6P9,RNU6-546P,RNU6-1001P,MTCYBP9,MTCO1P45,LINC01850,STAM2,NUDCP1
 
 newbury_08_ASD/DD_discovery_cases-patient1
 
 
 De novo
 Simplex
 NA
 UBQLN4P2,ATP5PBP4,RPRM,DNAJA1P2,PHBP4,RNA5SP107,CBX3P6,RNU6-1001P,MTCO1P45,MTND2P20,ATP5F1AP2,MTND4P28,MTND5P30,MTND6P9,MTCYBP9,RNU6-546P,ARL6IP6,RPL23AP29,FMNL2,PRPF40A,LINC01850,KCNJ3,GALNT13
 
 singh_20_DD/ID/EP_discovery_cases-case9
 FISH
 
 De novo
 
 
 PHBP4,RNA5SP107,CBX3P6,RNU6-1001P,MTCO1P45,MTND2P20,ATP5F1AP2,MTND4P28,MTND5P30,MTND6P9,MTCYBP9,RNU6-546P,RPLP0P7,CDK7P1,RN7SKP281,FAM133DP,NR4A2,LINC01958,ERMN,KCNJ3,GPD2,CYTIP,ACVR1C,GALNT13,LINC01876,GALNT5
 
 yuen_17_ASD_discovery_cases-case1-0484-003
 Affymetrix 6.0
 
 De novo
 Simplex
 Segregated
 RPL30P2,UBQLN4P2,ATP5PBP4,RPRM,DNAJA1P2,PHBP4,RNA5SP107,CBX3P6,RNU6-1001P,MTCO1P45,MTND2P20,ATP5F1AP2,MTND4P28,MTND5P30,MTND6P9,MTCYBP9,RNU6-546P,RPLP0P7,CDK7P1,RN7SKP281,FAM133DP,RNU6-436P,RNU6-932P,PTP4A1P1,UPP2-IT1,HNRNPDLP2,RN7SL393P,ARL5A,ARL6IP6,RPL23AP29,NR4A2,LINC01958,ERMN,NEB,STAM2,FMNL2,PRPF40A,LINC01850,KCNJ3,GPD2,CYTIP,ACVR1C,ACVR1,UPP2,CCDC148-AS1,PKP4,CACNB4,GALNT13,LINC01876,GALNT5,CCDC148
 
 yuen_17_ASD_discovery_cases-case1-0836-003
 Affymetrix CytoScan HD
 
 Unknown
 Simplex
 Unknown
 PHBP4,RNA5SP107,CBX3P6,RNU6-1001P,MTCO1P45,MTND2P20,ATP5F1AP2,MTND4P28,MTND5P30,MTND6P9,MTCYBP9,RNU6-546P,RPLP0P7,NR4A2,LINC01958,KCNJ3,GPD2,GALNT13,LINC01876
 
 zarrei_19_ASD/ADHD/OCD/SCZ_discovery_cases-case1-0836-003
 RT-qPCR or WGS
 
 Unknown
 
 
 PHBP4,RNA5SP107,CBX3P6,RNU6-1001P,MTCO1P45,MTND2P20,ATP5F1AP2,MTND4P28,MTND5P30,MTND6P9,MTCYBP9,RNU6-546P,RPLP0P7,NR4A2,LINC01958,KCNJ3,GPD2,GALNT13,LINC01876
 null

Controls

Patient ID
Validation Description
Primary Disorder Inheritence
Inheritence
Family Profile
Disease Segregation
Gene Content
Altered Gene Expression
girirajan_13a_ASD_discovery_controls2-control25
 
 
  Unknown
 
 
  GALNT13
 

No Animal Model Data Available
HELP
Copyright © 2017 MindSpec, Inc.